Pretect AS | HPV | Cervical Cancer Prevention | Gentian
17743
page-template,page-template-full_width,page-template-full_width-php,page,page-id-17743,page-child,parent-pageid-15948,ajax_fade,page_not_loaded,,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-14.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.5.5,vc_responsive
 

PreTect AS

PreTect AS

HPV and Cervical Cancer prevention

PreTect AS is a Norwegian research-based company that develops and manufactures high quality in vitro diagnostic (IVD) reagents. All research, development and manufacturing are performed in-house at our HQ in Norway.

 

As company, we have a clear focus to improve early detection of cervical disease and prevent cervical cancer with our HPV mRNA products. We carefully focus on the needs of patients and users, by continued innovation and application of new technology.

 

PreTect AS has several valid patents within the field of HPV mRNA detection and prevention of cervical cancer in Europe and US. Our vision “PreTect shall give all people a better daily life through development, production and marketing of products for efficient and safe diagnostics and treatment“ is achieved through fulfilment of all applicable laws, regulations and the NS-EN ISO 13485 standard.

Pretect Products

HPV mRNA E6/E7 - Focus on the infection that matters

PreTect offers IVD kits targeting high-risk HPV mRNA from the E6/E7 oncogenes for a risk based approach in cervical cancer prevention.   By focusing on the limited number of genotypes associated with cervical cancer, women at highest risk of developing severe cervical disease can be identified.

The products utilities Nucleic Acid Amplification-Based (NASBA) technology, an enzymatic one-step amplification process that is able to specifically amplify RNA in a dsDNA background under isothermal conditions (41°C).

Improved protection against Cervical Cancer.
PRETECT HPV-PROOFER
PRODUCT NO: 110101PreTect HPV-Proofer is a real-time Nucleic Acid Amplification-Based (NASBA) qualitative assay for specific genotyping of E6/E7 mRNA from HPV 16, HPV 18, HPV 31, HPV 33 and HPV 45 including Intrinsic Sample Control (ISC).
PreTect SEE
PRODUCT NO: 110301PreTect SEE is a real-time Nucleic Acid Amplification-Based (NASBA) qualitative assay for specific genotyping of E6/E7 mRNA from HPV 16, HPV 18 and HPV 45, including Intrinsic Sample Control (ISC).
Service provision
HPV mRNA Service ProvisionPreTect offers service provision with short turnaround time for all our HPV mRNA assays. This is a cost-effective service for customers as there is no need to invest in new equipment or implement new methods in their busy laboratory environment. Get in contact for a customised quotation.

Contact Pretect AS

Get in touch

Please fill out the form below.

X
CONTACT US